gip and glp 1 receptor agonist Major physiological roles of GLP-1 GIP. Tirzepatide is acting as an Alimentary Pharmacology & Therapeutics |

Pooled analyses across the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM trials confirmed a consistent reduction in heart failure events among 3743 participants with HFpEF [93]

While newer and stronger drugs exist, Saxenda is still a safe, effective, and reliable option when used under proper medical supervision

Beyond glycemic control, large outcome studies have confirmed that certain GLP-1 agonists significantly improve cardiovascular outcomes (reducing heart attacks, stroke, or cardiovascular death) in high-risk diabetic patients ( [8] ) ( [9] )

Fujiwara Y, Yamane S, Harada N, Ikeguchi-Ogura E, Usui R, Nakamura T, et al

Quinkler M, Sinha B, Tomlinson JW, Bujalska IJ, Stewart PM, Arlt W

Amongst the three predominant HF phenotypes (HF with preserved, mildly reduced or reduced ejection fraction